ClinicalTrials.gg
Drug class

Chelating Agents clinical trials

A class of medicines: the studies that test any of its 16 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
161
open now
10
in phase 3
27
first study started
1992

Keep track of what changes. Save the chelating agents studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Ditiocarb
2
Alanosine
2

Studies by the year they started

153 studies that test it; most in 2014 (11); 1 more planned to start later

Studies that test Chelating Agents, by start year
YearStudies
19921
19942
19971
19991
20001
20013
20021
20034
20044
20057
20068
20076
20089
20099
20109
20115
20125
20136
201411
20156
20164
20176
20189
20196
20209
20212
20222
20236
20246
20251
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
32
Phase 2
54
Phase 3
27
Phase 4
18
No phase
37

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 47 · Other 114

Alexion Pharmaceuticals, Inc. (14) · Genzyme, a Sanofi Company (11) · EmeraMed (5) · M.D. Anderson Cancer Center (4) · University of Michigan Rogel Cancer Center (3) · Aarhus University Hospital (3) · Ruhr University of Bochum (3) · National Center for Research Resources (NCRR) (3)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing one of them · 161

See all 161 studies that test one of the chelating agents →